VEGFR/PDGFR inhibitors (Xcovery)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameVEGFR/PDGFR inhibitors (Xcovery)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor antagonistsPlatelet-derived growth factor receptor inhibitors
TargetsPlatelet-derived growth factor receptorVascular endothelial growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXcovery
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXcovery
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A